Correlation Between Indaptus Therapeutics and Maravai Lifesciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Maravai Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Maravai Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Maravai Lifesciences Holdings, you can compare the effects of market volatilities on Indaptus Therapeutics and Maravai Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Maravai Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Maravai Lifesciences.

Diversification Opportunities for Indaptus Therapeutics and Maravai Lifesciences

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Indaptus and Maravai is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Maravai Lifesciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maravai Lifesciences and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Maravai Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maravai Lifesciences has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Maravai Lifesciences go up and down completely randomly.

Pair Corralation between Indaptus Therapeutics and Maravai Lifesciences

Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 1.06 times more return on investment than Maravai Lifesciences. However, Indaptus Therapeutics is 1.06 times more volatile than Maravai Lifesciences Holdings. It trades about 0.01 of its potential returns per unit of risk. Maravai Lifesciences Holdings is currently generating about -0.01 per unit of risk. If you would invest  156.00  in Indaptus Therapeutics on September 12, 2024 and sell it today you would lose (56.00) from holding Indaptus Therapeutics or give up 35.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Indaptus Therapeutics  vs.  Maravai Lifesciences Holdings

 Performance 
       Timeline  
Indaptus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Indaptus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Maravai Lifesciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maravai Lifesciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Indaptus Therapeutics and Maravai Lifesciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Indaptus Therapeutics and Maravai Lifesciences

The main advantage of trading using opposite Indaptus Therapeutics and Maravai Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Maravai Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will offset losses from the drop in Maravai Lifesciences' long position.
The idea behind Indaptus Therapeutics and Maravai Lifesciences Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios